Ultra-High Mass Resolution MALDI Imaging Mass Spectrometry of Proteins and Metabolites in a Mouse Model of Glioblastoma
暂无分享,去创建一个
L. McDonnell | M. Caleo | S. Nicolardi | C. Esteve | E. Vannini | M. Dilillo | M. Costa | D. Pellegrini | E. L. Graaf | R. Ait‐Belkacem | Mario Costa
[1] F. Sotgia,et al. Cancer metabolism: a therapeutic perspective , 2017, Nature Reviews Clinical Oncology.
[2] Laura M. Cole,et al. Imaging Mass Spectrometry , 2017, Methods in Molecular Biology.
[3] L. McDonnell,et al. Electrophysiology of glioma: a Rho GTPase-activating protein reduces tumor growth and spares neuron structure and function. , 2016, Neuro-Oncology.
[4] L. McDonnell,et al. Set of Novel Automated Quantitative Microproteomics Protocols for Small Sample Amounts and Its Application to Kidney Tissue Substructures. , 2016, Journal of proteome research.
[5] L. McDonnell,et al. Funnel‐freezing versus heat‐stabilization for the visualization of metabolites by mass spectrometry imaging in a mouse stroke model , 2016, Proteomics.
[6] Eric P Skaar,et al. Next‐generation technologies for spatial proteomics: Integrating ultra‐high speed MALDI‐TOF and high mass resolution MALDI FTICR imaging mass spectrometry for protein analysis , 2016, Proteomics.
[7] A. Feuchtinger,et al. In situ detection of histone variants and modifications in mouse brain using imaging mass spectrometry , 2016, Proteomics.
[8] L. McDonnell,et al. Mass spectrometry imaging of amino neurotransmitters: a comparison of derivatization methods and application in mouse brain tissue , 2016, Metabolomics.
[9] Tyler E. Miller,et al. An epigenetic gateway to brain tumor cell identity , 2015, Nature Neuroscience.
[10] Eric P Skaar,et al. MALDI FTICR IMS of Intact Proteins: Using Mass Accuracy to Link Protein Images with Proteomics Data , 2015, Journal of The American Society for Mass Spectrometry.
[11] M. Belting,et al. Global Profiling of Metabolic Adaptation to Hypoxic Stress in Human Glioblastoma Cells , 2015, PloS one.
[12] J. Denu,et al. Metabolic regulation of histone post-translational modifications. , 2015, ACS chemical biology.
[13] Bram Heijs,et al. Comprehensive analysis of the mouse brain proteome sampled in mass spectrometry imaging. , 2015, Analytical chemistry.
[14] J. Yates,et al. Isobaric Labeling-Based Relative Quantification in Shotgun Proteomics , 2014, Journal of proteome research.
[15] Y. Hannun,et al. On-Tissue Localization of Ceramides and Other Sphingolipids by MALDI Mass Spectrometry Imaging , 2014, Analytical chemistry.
[16] C. Fiorentini,et al. The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model , 2014, BMC Cancer.
[17] M. Suematsu,et al. Visualization and quantification of cerebral metabolic fluxes of glucose in awake mice , 2014, Proteomics.
[18] Garry L Corthals,et al. MSiMass list: a public database of identifications for protein MALDI MS imaging. , 2014, Journal of proteome research.
[19] G. Reifenberger,et al. Thymosin β 4 gene silencing decreases stemness and invasiveness in glioblastoma. , 2014, Brain : a journal of neurology.
[20] T. Seyfried,et al. Cancer as a metabolic disease: implications for novel therapeutics , 2013, Carcinogenesis.
[21] J. Meier. Metabolic mechanisms of epigenetic regulation. , 2013, ACS chemical biology.
[22] Theodore Alexandrov,et al. Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas , 2013, Hepatology.
[23] B. Kamińska,et al. Is Glioblastoma an Epigenetic Malignancy? , 2013, Cancers.
[24] W. Mason,et al. Emerging Biomarkers in Glioblastoma , 2013, Cancers.
[25] Benjamin A Garcia,et al. Proteomic characterization of novel histone post-translational modifications , 2013, Epigenetics & Chromatin.
[26] Anushya Muruganujan,et al. Large-scale gene function analysis with the PANTHER classification system , 2013, Nature Protocols.
[27] Bernhard Kuster,et al. Comprehensive Identification of Proteins from MALDI Imaging* , 2013, Molecular & Cellular Proteomics.
[28] M. Fischer,et al. Influence of various on-tissue washing procedures on the entire protein quantity and the quality of matrix-assisted laser desorption/ionization spectra. , 2013, Rapid Communications in Mass Spectrometry.
[29] John C. Price,et al. Mass spectrometry imaging for in situ kinetic histochemistry , 2013, Scientific Reports.
[30] S. Nicolardi,et al. Identification of new apolipoprotein-CIII glycoforms with ultrahigh resolution MALDI-FTICR mass spectrometry of human sera. , 2013, Journal of proteome research.
[31] Philippe Dessen,et al. Atlas of Genetics and Cytogenetics in Oncology and Haematology in 2013 , 2012, Nucleic Acids Res..
[32] Steven Eschrich,et al. Molecular and Cellular Pathobiology The Metabolomic Signature of Malignant Glioma Re fl ects Accelerated Anabolic Metabolism , 2012 .
[33] S. Rauser,et al. S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI Imaging , 2012, Journal of Molecular Medicine.
[34] Richard M Caprioli,et al. Protein signatures for survival and recurrence in metastatic melanoma. , 2011, Journal of proteomics.
[35] S. Marie,et al. Metabolism and Brain Cancer , 2011, Clinics.
[36] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[37] S. Gygi,et al. ms3 eliminates ratio distortion in isobaric multiplexed quantitative , 2011 .
[38] Liam A. McDonnell,et al. Imaging mass spectrometry data reduction: Automated feature identification and extraction , 2010, Journal of the American Society for Mass Spectrometry.
[39] A. Guha,et al. Targeting Metabolic Remodeling in Glioblastoma Multiforme , 2010, Oncotarget.
[40] L. McDonnell,et al. Peptide and protein imaging mass spectrometry in cancer research. , 2010, Journal of proteomics.
[41] M. Ohmura,et al. Paradoxical ATP elevation in ischemic penumbra revealed by quantitative imaging mass spectrometry. , 2010, Antioxidants & redox signaling.
[42] H. Shim,et al. Molecular proteomics imaging of tumor interfaces by mass spectrometry. , 2010, Journal of proteome research.
[43] D. Wishart. Applications of Metabolomics in Drug Discovery and Development , 2008, Drugs in R&D.
[44] C. Allis,et al. Extraction, purification and analysis of histones , 2007, Nature Protocols.
[45] J. Xu,et al. Ribosomal proteins and colorectal cancer. , 2007, Current genomics.
[46] P. Chaurand,et al. Processing MALDI Mass Spectra to Improve Mass Spectral Direct Tissue Analysis. , 2007, International journal of mass spectrometry.
[47] G. Collins. The next generation. , 2006, Scientific American.
[48] Ioannis Panagopoulos,et al. Atlas of Genetics and Cytogenetics in Oncology and Haematology , 2005 .
[49] M. Mori,et al. Ubiquitin fusion proteins are overexpressed in colon cancer but not in gastric cancer. , 1995, Biochimica et biophysica acta.
[50] C. Williamson,et al. Therapeutic perspective. , 1951, California medicine.